Cytochroma and Genzyme settle lawsuit

NewsGuard 100/100 Score

Cytochroma has announced that the lawsuit filed in August 2006 by Genzyme Corporation in the United States District Court, Western District of Wisconsin has been settled by the parties.

On August 8, 2006, Genzyme filed a complaint in the United States District Court, Western District of Wisconsin against Cytochroma Inc., Proventiv Therapeutics LLC and three former Bone Care International employees. The complaint, alleging misappropriation of Vitamin D-related trade secrets, was amicably resolved and the case has been formally dismissed. The terms of the settlement were not disclosed.

"Cytochroma has remained on track for meeting its financing and clinical development milestones despite the intercurrent lawsuit," commented Dr. Alan Lewis, Chairman of the Board. "The recent settlement with Genzyme adds further momentum to Cytochroma for achieving its corporate objectives."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.